Phosgene Poisoning Caused by the Use of Chemical Paint Removers Containing Methylene Chloride in Ill-Ventilated Rooms Heated by Kerosene Stoves

par Gerritsen, W. B., Buschmann, C. H.
Publié 1960

Metastatic castration-resistant prostate cancer: new therapies, novel combination strategies and implications for immunotherapy

par Drake, CG, Sharma, P, Gerritsen, W
Publié dans Oncogene (2013)

Overexpression of Bcl2 abrogates chemo- and radiotherapy-induced sensitisation of NCI-H460 non-small-cell lung cancer cells to adenovirus-mediated expression of full-length TRAIL

par Abou El Hassan, M A I, Mastenbroek, D C J, Gerritsen, W R, Giaccone, G, Kruyt, F A E
Publié 2004

S48. Biomarker development for ipilimumab and prostate GVAX treatment

par de Gruijl, T, Santegoets, S, Stam, A, Lougheed, S, Jooss, K, Sacks, N, Harding, T, Hege, K, Gerritsen, W, van den Eertwegh, A
Publié 2014

Redirecting Coronavirus to a Nonnative Receptor through a Virus-Encoded Targeting Adapter

par Verheije, M. H., Würdinger, T., van Beusechem, V. W., de Haan, C. A. M., Gerritsen, W. R., Rottier, P. J. M.
Publié 2006

Cloning and characterization of human liver cytosolic beta-glycosidase.

par de Graaf, M, van Veen, I C, van der Meulen-Muileman, I H, Gerritsen, W R, Pinedo, H M, Haisma, H J
Publié 2001

Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenografts

par Geoerger, B, Grill, J, Opolon, P, Morizet, J, Aubert, G, Lecluse, Y, van Beusechem, V W, Gerritsen, W R, Kirn, D H, Vassal, G
Publié 2003

A fully human anti-Ep-CAM scFv-beta-glucuronidase fusion protein for selective chemotherapy with a glucuronide prodrug

par de Graaf, M, Boven, E, Oosterhoff, D, van der Meulen-Muileman, I H, Huls, G A, Gerritsen, W R, Haisma, H J, Pinedo, H M
Publié 2002

Targeting non-human coronaviruses to human cancer cells using a bispecific single-chain antibody

par Würdinger, T, Verheije, M H, Raaben, M, Bosch, B J, de Haan, C A M, van Beusechem, V W, Rottier, P J M, Gerritsen, W R
Publié dans Gene Ther (2005)

Advances in targeted alpha therapy for prostate cancer

par De Vincentis, G, Gerritsen, W, Gschwend, J E, Hacker, M, Lewington, V, O’Sullivan, J M, Oya, M, Pacilio, M, Parker, C, Shore, N, Sartor, O
Publié dans Ann Oncol (2019)

S100 protein content of umbilical cord blood in healthy newborns in relation to mode of delivery

par Wirds, J, Duyn, A, Geraerts, S, Preijer, E, van Diemen-Steenv..., J A A M, van Leeuwen, J H S., Haas, F, Gerritsen, W, de Boer, A, Leusink, J
Publié 2003

Secreted and tumour targeted human carboxylesterase for activation of irinotecan

par Oosterhoff, D, Pinedo, H M, van der Meulen, I H, de Graaf, M, Sone, T, Kruyt, F A, van Beusechem, V W, Haisma, H J, Gerritsen, W R
Publié 2002

Soluble Receptor-Mediated Targeting of Mouse Hepatitis Coronavirus to the Human Epidermal Growth Factor Receptor

par Würdinger, T., Verheije, M. H., Broen, K., Bosch, B. J., Haijema, B. J., de Haan, C. A. M., van Beusechem, V. W., Gerritsen, W. R., Rottier, P. J. M.
Publié 2005

Adenoviral vector-mediated expression of a gene encoding secreted, EpCAM-targeted carboxylesterase-2 sensitises colon cancer spheroids to CPT-11

par Oosterhoff, D, Overmeer, R M, de Graaf, M, van der Meulen, I H, Giaccone, G, van Beusechem, V W, Haisma, H J, Pinedo, H M, Gerritsen, W R
Publié 2005

Antibody-mediated targeting of viral vectors to the Fc receptor expressed on acute myeloid leukemia cells

par Würdinger, T, Verheije, M H, van der Aa, L M, Bosch, B J, de Haan, C A M, van Beusechem, V W, Gerritsen, W R, Rottier, P J M
Publié dans Leukemia (2006)

HGF/SF and its receptor c-MET play a minor role in the dissemination of human B-lymphoma cells in SCID mice

par Weimar, I S, Weijer, K, Berk, P C M van den, Muller, E J, Miranda, N, Bakker, A Q, Heemskerk, M H M, Hekman, A, Gast, G C de, Gerritsen, W R
Publié 1999

Different susceptibility of osteosarcoma cell lines and primary cells to treatment with oncolytic adenovirus and doxorubicin or cisplatin

par Graat, H C A, Witlox, M A, Schagen, F H E, Kaspers, G J L, Helder, M N, Bras, J, Schaap, G R, Gerritsen, W R, Wuisman, P I J M, van Beusechem, V W
Publié 2006

Inhibition of platelet function by abciximab or high-dose tirofiban in patients with STEMI undergoing primary PCI: a randomised trial

par van Werkum, J.W., Gerritsen, W.B.M., Kelder, J.C., Hackeng, C.M., Ernst, S.M., Deneer, V.H.M., Suttorp, M.J., Rensing, B.J.W.M., Plokker, H.W.M., ten Berg, J.M.
Publié 2007

Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up

par Fradet, Y, Bellmunt, J, Vaughn, D J, Lee, J L, Fong, L, Vogelzang, N J, Climent, M A, Petrylak, D P, Choueiri, T K, Necchi, A, Gerritsen, W, Gurney, H, Quinn, D I, Culine, S, Sternberg, C N, Nam, K, Frenkl, T L, Perini, R F, de Wit, R, Bajorin, D F
Publié dans Ann Oncol (2019)

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

par Bellmunt, J., de Wit, R., Vaughn, D.J., Fradet, Y., Lee, J.-L., Fong, L., Vogelzang, N.J., Climent, M.A., Petrylak, D.P., Choueiri, T.K., Necchi, A., Gerritsen, W., Gurney, H., Quinn, D.I., Culine, S., Sternberg, C.N., Mai, Y., Poehlein, C.H., Perini, R.F., Bajorin, D.F.
Publié dans N Engl J Med (2017)